IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

Arun has over 15 years’ experience covering the Technology sector. During this time, he has worked with technology start-ups and as an equity analyst in investment banks and independent research firms. He was formerly a Technology Analyst for Canaccord Genuity, Altium Securities, Espirito Santo Investment Bank, Noble Group and Clear Capital. He has a dual Master’s degree in Financial Engineering and Industrial and Operations Engineering from the University of Michigan. He obtained his Bachelor’s degree in Mechanical Engineering from the Indian Institute of Technology, Bombay. He is also a CFA charterholder.

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/oue-healthcare-limited" target="_blank" data-smartkarma-citation="entities:562:1" rel="noopener">OUE Healthcare (OUEHC SP)</a> disclosed a scheme offer from <a href="https://www.smartkarma.com/entities/oue-limited" target="_blank" data-smartkarma-citation="entities:9984:1" rel="noopener">OUE (OUE SP)</a> at S$0.05 per share, a 28.2% premium to the undisturbed price of S$0.039 (21 August). </li>
<li>The offer represents a 6-year high and is attractive compared to precedent transactions and peer multiples.</li>
<li>The scheme vote is low risk as no disinterested shareholder holds a blocking stake. At the last close and for a 31 December payment, the gross/annualised spread was 4.2%/11.7%.</li>
</ul>



OUE Healthcare (OUEHC SP) disclosed a scheme offer from OUE (OUE SP) at S$0.05 per share, a 28.2% premium to the undisturbed price of S$0.039 (21 August). 
The offer represents a 6-year high and is attractive compared to precedent transactions and peer multiples.
The scheme vote is low risk as no disinterested shareholder holds a blocking stake. At the last close and for a 31 December payment, the gross/annualised spread was 4.2%/11.7%.


OUE Healthcare (OUEHC SP): OUE Limited’s Scheme Offer a Done Deal